Dian Diagnostics Group Co Ltd
SZSE:300244

Watchlist Manager
Dian Diagnostics Group Co Ltd Logo
Dian Diagnostics Group Co Ltd
SZSE:300244
Watchlist
Price: 10.82 CNY -1.99%
Market Cap: 6.8B CNY
Have any thoughts about
Dian Diagnostics Group Co Ltd?
Write Note

Dian Diagnostics Group Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dian Diagnostics Group Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Dian Diagnostics Group Co Ltd
SZSE:300244
Long-Term Debt
ÂĄ2.1B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Long-Term Debt
ÂĄ543.7m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Long-Term Debt
ÂĄ1.2B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Long-Term Debt
ÂĄ500m
CAGR 3-Years
-3%
CAGR 5-Years
37%
CAGR 10-Years
-6%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Long-Term Debt
ÂĄ2.7B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
62%
Jiangxi Rimag Group Co Ltd
HKEX:2522
Long-Term Debt
ÂĄ221.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dian Diagnostics Group Co Ltd
Glance View

Market Cap
6.8B CNY
Industry
Health Care

Nestled in the bustling city of Hangzhou, Dian Diagnostics Group Co Ltd has carved out a pivotal role in China's healthcare landscape. Established in 1996, the company's journey began with the humble yet crucial task of providing diagnostic services. Over the years, as the wave of technological innovation swept across the globe, Dian Diagnostics harnessed its potential to expand its service offerings, evolving into a comprehensive medical diagnostics powerhouse. The company operates through its expansive network of diagnostic laboratories, which leverage cutting-edge tools to deliver precise and timely results. This network serves hospitals, clinics, and other healthcare establishments, thus forming a vital link in the healthcare delivery chain. The heart of Dian Diagnostics' business model lies in its ability to integrate advanced technological solutions with healthcare needs, ensuring scalability and efficiency. The company's revenue streams primarily flow from the provision of diagnostic testing services and sales of diagnostic equipment and reagents. Owing to its commitment to innovation, Dian Diagnostics invests heavily in research and development, continuously enhancing its offerings in molecular diagnostics, pathology, and healthcare IT solutions. By catering to the ever-growing demand for reliable and rapid diagnostic services, the company sustains its growth momentum while contributing significantly to the advancement of healthcare quality in China.

Intrinsic Value
28.73 CNY
Undervaluation 62%
Intrinsic Value
Price

See Also

What is Dian Diagnostics Group Co Ltd's Long-Term Debt?
Long-Term Debt
2.1B CNY

Based on the financial report for Sep 30, 2024, Dian Diagnostics Group Co Ltd's Long-Term Debt amounts to 2.1B CNY.

What is Dian Diagnostics Group Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
15%

Over the last year, the Long-Term Debt growth was -18%. The average annual Long-Term Debt growth rates for Dian Diagnostics Group Co Ltd have been 24% over the past three years , 15% over the past five years .

Back to Top